Home » Topics » Regulatory » Patents

Patents
RSS

New EZH2 inhibitors synthesized at PharmaBlock Sciences

Nov. 30, 2020

Qilu Regor Therapeutics presents new CDK inhibitors

Nov. 30, 2020

New CD134 agonists identified at Bicycle Therapeutics

Nov. 30, 2020

Janssen discovers anti-HBV compounds

Nov. 30, 2020

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Abmax Biopharmaceuticals TNF-alpha-targeting antibodies

Nov. 27, 2020

Chaser Therapeutics identifies new USP28 and USP25 inhibitors

Nov. 27, 2020

Idorsia Pharmaceuticals synthesizes new PDK1 inhibitors

Nov. 27, 2020

TYK Medicines divulges protein kinase inhibitors

Nov. 27, 2020

Genfleet Therapeutics describes new RIPK1 inhibitors

Nov. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...